AtriCure ROA 2006-2018 | ATRC

Current and historical return on assets (ROA) values for AtriCure (ATRC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. AtriCure ROA for the three months ending September 30, 2018 was -9.99%.
AtriCure ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.02B $0.27B -7.40%
2018-06-30 $-0.02B $0.27B -7.43%
2018-03-31 $-0.03B $0.27B -10.05%
2017-12-31 $-0.03B $0.27B -10.08%
2017-09-30 $-0.03B $0.27B -12.23%
2017-06-30 $-0.03B $0.27B -12.11%
2017-03-31 $-0.03B $0.27B -12.33%
2016-12-31 $-0.03B $0.28B -12.37%
2016-09-30 $-0.04B $0.28B -13.14%
2016-06-30 $-0.04B $0.28B -14.24%
2016-03-31 $-0.03B $0.26B -14.88%
2015-12-31 $-0.03B $0.27B -14.38%
2015-09-30 $-0.02B $0.17B -13.21%
2015-06-30 $-0.02B $0.16B -9.57%
2015-03-31 $-0.01B $0.15B -8.33%
2014-12-31 $-0.02B $0.16B -10.16%
2014-09-30 $-0.02B $0.16B -10.96%
2014-06-30 $-0.02B $0.16B -15.67%
2014-03-31 $-0.02B $0.16B -18.65%
2013-12-31 $-0.01B $0.11B -16.84%
2013-09-30 $-0.01B $0.06B -17.56%
2013-06-30 $-0.01B $0.06B -19.89%
2013-03-31 $-0.01B $0.06B -20.00%
2012-12-31 $-0.01B $0.03B -23.02%
2012-09-30 $-0.01B $0.03B -22.70%
2012-06-30 $-0.01B $0.04B -17.02%
2012-03-31 $-0.01B $0.04B -17.02%
2011-12-31 $-0.01B $0.03B -14.18%
2011-09-30 $-0.00B $0.03B -8.51%
2011-06-30 $-0.00B $0.04B -8.39%
2011-03-31 $-0.00B $0.04B -8.45%
2010-12-31 $-0.00B $0.03B -11.59%
2010-09-30 $-0.01B $0.04B -17.27%
2010-06-30 $-0.01B $0.04B -28.78%
2010-03-31 $-0.01B $0.03B -28.78%
2009-12-31 $-0.02B $0.04B -47.76%
2009-09-30 $-0.02B $0.04B -47.89%
2009-06-30 $-0.01B $0.04B -36.84%
2009-03-31 $-0.02B $0.03B -37.97%
2008-12-31 $-0.01B $0.04B -25.29%
2008-09-30 $-0.01B $0.05B -22.60%
2008-06-30 $-0.01B $0.04B -24.86%
2008-03-31 $-0.01B $0.04B -25.81%
2007-12-31 $-0.01B $0.05B -26.97%
2007-09-30 $-0.01B $0.05B -32.75%
2007-06-30 $-0.01B $0.05B -33.53%
2007-03-31 $-0.01B $0.04B -34.78%
2006-12-31 $-0.01B $0.04B -30.23%
2006-09-30 $-0.01B $0.04B -28.42%
2006-06-30 $-0.01B $0.04B -28.72%
2006-03-31 $-0.01B $0.05B -31.71%
2005-12-31 $-0.01B $0.05B -41.03%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.241B $0.175B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00